UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB ) Receptor Antagonist, Rimonabant (SR141716)

Neuropsychopharmacology (New York, N.Y.), 2005-01, Vol.30 (1), p.145-155

2005

Volltextzugriff (PDF)

CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

The FASEB journal, 2005-09, Vol.19 (11), p.1567-1569

2005

Volltextzugriff (PDF)

Rimonabant reduces obesity‐associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

Hepatology (Baltimore, Md.), 2007-07, Vol.46 (1), p.122-129

2007

Volltextzugriff (PDF)

Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice

Neuroscience letters, 2003-06, Vol.343 (3), p.216-218

2003

Volltextzugriff (PDF)

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

Psychopharmacologia, 1997-07, Vol.132 (1), p.104-106

1997

Volltextzugriff (PDF)

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

FEBS letters, 1994-08, Vol.350 (2), p.240-244

1994

Volltextzugriff (PDF)

Anxiolytic- and Antidepressant-like Effects of the Non-Peptide Vasopressin V1b Receptor Antagonist, SSR149415, Suggest an Innovative Approach for the Treatment of Stress-Related Disorders

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (9), p.6370-6375

2002

Volltextzugriff (PDF)

Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia

Brain research, 2002-10, Vol.953 (1), p.63-72

2002

Volltextzugriff (PDF)

Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents

Psychopharmacologia, 2001-11, Vol.158 (3), p.241-251

2001

Volltextzugriff (PDF)

Blockade by the cannabinoid CBI receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior

Neuropsychopharmacology (New York, N.Y.), 2004-05, Vol.29 (5), p.911-920

2004

Volltextzugriff (PDF)

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

American journal of physiology. Regulatory, integrative and comparative physiology, 2003-02, Vol.284 (2), p.345-R353

2003

Volltextzugriff (PDF)

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

European journal of pharmacology, 1993-12, Vol.250 (3), p.403-413

1993

Volltextzugriff (PDF)

Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery

Neuroscience and biobehavioral reviews, 2001-12, Vol.25 (7-8), p.619-626

2001

Volltextzugriff (PDF)

EFFECTS OF CB1 CANNABINOID RECEPTOR BLOCKADE ON ETHANOL PREFERENCE AFTER CHRONIC ALCOHOL ADMINISTRATION COMBINED WITH REPEATED RE-EXPOSURES AND WITHDRAWALS

Alcohol and alcoholism (Oxford), 2004-11, Vol.39 (6), p.486-492

2004

Volltextzugriff (PDF)

Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis

Life sciences (1973), 1996, Vol.58 (6), p.PL103-PL110

1996

Volltextzugriff (PDF)

Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors

Naunyn-Schmiedeberg's archives of pharmacology, 1995-11, Vol.352 (5), p.576-579

1995

Volltextzugriff (PDF)

Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells

The Journal of physiology, 1998-08, Vol.510 (3), p.867-879

1998

Volltextzugriff (PDF)

Expression of tachykinin NK2 receptor mRNA in human brain

Neuroscience letters, 2001-04, Vol.303 (1), p.25-28

2001

Volltextzugriff (PDF)

Specific involvement of neurotensin type 1 receptor in the neurotensin‐mediated in vivo dopamine efflux using knock‐out mice

Journal of neurochemistry, 2004-04, Vol.89 (1), p.1-6

2004

Volltextzugriff (PDF)

Cannabinoids Modulate Synaptic Strength and Plasticity at Glutamatergic Synapses of Rat Prefrontal Cortex Pyramidal Neurons

Journal of neurophysiology, 2000-06, Vol.83 (6), p.3287-3293

2000

Volltextzugriff (PDF)

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V 1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (9), p.6370-6375

2002

Volltextzugriff (PDF)

Effects of SR48968, a selective non-peptide NK 2 receptor antagonist on emotional processes in rodents

Psychopharmacology, 2001-11, Vol.158 (3), p.241-251

2001

Volltextzugriff (PDF)

The new neurokinin 1‐sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA‐evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum

Journal of neurochemistry, 2003-10, Vol.87 (2), p.487-496

2003

Volltextzugriff (PDF)

SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: Behavioral profile predictive of an atypical antipsychotic activity

Neuropsychopharmacology (New York, N.Y.), 2003-11, Vol.28 (11), p.1889-1902

2003

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)

Publikationsform

Artikel
(112)

Sprache

Englisch
(112)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Animals
(81)
Science & Technology
(78)
Life Sciences & Biomedicine
(75)
Male
(64)
Biological And Medical Sciences
(57)
Rats
(57)
Neurosciences
(43)
Neurosciences & Neurology
(43)
Pharmacology & Pharmacy
(42)
Medical Sciences
(36)
Mice
(32)
Piperidines - Pharmacology
(30)
Rats, Sprague-Dawley
(30)
Pharmacology. Drug Treatments
(28)
Neuropharmacology
(27)
Psychology. Psychoanalysis. Psychiatry
(26)
Pyrazoles - Pharmacology
(22)
Fundamental And Applied Biological Sciences. Psychology
(21)
Psychiatry
(20)
Psychopharmacology
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB ) Receptor Antagonist, Rimonabant (SR141716)

CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

Rimonabant reduces obesity‐associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic

Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Anxiolytic- and Antidepressant-like Effects of the Non-Peptide Vasopressin V1b Receptor Antagonist, SSR149415, Suggest an Innovative Approach for the Treatment of Stress-Related Disorders

Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia

Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents

Blockade by the cannabinoid CBI receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery

EFFECTS OF CB1 CANNABINOID RECEPTOR BLOCKADE ON ETHANOL PREFERENCE AFTER CHRONIC ALCOHOL ADMINISTRATION COMBINED WITH REPEATED RE-EXPOSURES AND WITHDRAWALS

Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis

Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors

Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells

Expression of tachykinin NK2 receptor mRNA in human brain

Specific involvement of neurotensin type 1 receptor in the neurotensin‐mediated in vivo dopamine efflux using knock‐out mice

Cannabinoids Modulate Synaptic Strength and Plasticity at Glutamatergic Synapses of Rat Prefrontal Cortex Pyramidal Neurons

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V 1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Effects of SR48968, a selective non-peptide NK 2 receptor antagonist on emotional processes in rodents

The new neurokinin 1‐sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA‐evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum

SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: Behavioral profile predictive of an atypical antipsychotic activity

Aktive Filter

Suchergebnisse filtern